Ruffer’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Ruffer's JAZZ Position: Q3 2026 in Review
Ruffer sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2026, closing a stake of 24,567 shares — an estimated $5.91M sold.
Ruffer first reported a position in JAZZ in Q2 2021 and held it in 15 quarters. The position peaked at $7.24M in Q4 2024. 538 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Ruffer reported no remaining Jazz Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Ruffer sold 24,567 Jazz Pharmaceuticals shares in Q3 2026, an estimated $5.91M.
- Ruffer first reported a position in Jazz Pharmaceuticals in Q2 2021 and held it in 15 quarters.
- Ruffer's Jazz Pharmaceuticals position peaked at $7.24M in Q4 2024.
- 538 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Ruffer's 13F filing for Q3 2026, filed 10 Nov 2026.